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ABSTRACT
Competitive athletes often present musculoskeletal injuries, some of these nontraumatic. Usually 
these injuries are attributed to mechanical factors. The present study aimed to investigate a group of 
handball players and check a possible action of immune-inflammatory and hormonal factors in the 
genesis of these lesions. Laboratory parameters were studied measuring in the plasma the concentration 
of plasma hormones and neurotransmitters, and production “in vitro” of cytokines and prostaglandin 
E2. The results indicate that in 29% of the athletes included in the study the occurrence of nontrau-
matic musculoskeletal injuries was observed. In this group there was an increased production of pro-
inflammatory cytokines assayed in the supernatant of culture of peripheral blood cells with increased 
concentrations of IL-1, IL-2, TNF-α and IFN-α, as well of prostaglandin E2.
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INTRODUCTION
Overload of the musculoskeletal system is intrinsic to sports practice 
and within physiological thersholds, there is a compensation. However, 
excessive or miscompensated overload hampers a suitable rebalance 
process, leading to disorganization of the system causing injuries1. 
These injuries are classified as nontraumatic or injuries by excessive 
use (overuse syndromes) which, when causing microtrauma by the 
application of shear stress will be compensated until this additional 
stress results in injury2. The decreased contractibility of fatigued muscles 
limits their capacity to absorb shock and stress1. Training volume is also 
mentioned as cause of this kind of injury 2, being suggested that in 
runners there is a direct relation between mileage and onset of this 
kind of trauma.
Hill et al.3, in a study in which they followed female softball 
players for a two-year period, showed that more than 70% of the 
athletes presented musculoskeletal injuries and that 70% of these 
were related to injury mechanisms by overtraining, demonstrating 
the importance of this mechanism. Other factors were mentioned 
by Ekstrand et al.4, who, when following the national Sweden soccer 
senior team for seven years, found out that injury incidence was 
five times higher after competitive matches when compared with 
training. It has also been demonstrated that the number of injuries 
significantly increased when the team lost the games, suggesting 
that non-mechanical factors could be involved in the genesis of 
nontraumatic injuries.
Small5 observed that 80% of the complaints reported in 
sports medicine clinics referred to pain and that in the absence 
of trauma, fibromyalgia6 was one of the main causes associated to 
pain triggering. Cramer7 also suggests that athletes can present a 
situation similar to the chronic fatigue syndrome and that these 
can be associated with the onset of musculoskeletal injury. This 
author highlights the need to distance viral pathology, stress, 
depression or exposure to environmental toxin8. When observing 
athletes, Vaisberg et al.9 observed that complaints of muscular pain 
occur in high proportion in track and field and Olympic gymnastics 
practitioners, as well as the need for winning as an important factor 
related to the development of anguish which was clearly associated 
with pain complaint10. 
Ader and Cohen11 and Besedovsky et al.12, in the 1970’s, ex-
perimentally demonstrated the close functional relation between 
the neuroendocrine and immunological systems, which enabled 
an integrated view of the homeostatic mechanisms of the human 
body, providing physiopathological grounding which explain as 
alterations of psychological nature such as stress, anxiety and de-
pression present association with greater incidence of sports injuries 
without trauma. 
Recently, many studies in experimental models and humans 
demonstrated that psychological stress stimulates the production 
of pro-inflammatory cytokines17-19. Black20, in extensive review on 
the topic, shows that, in response to the psychological stress, an 
inflammatory process occurs by the release by sensory nerves of 
neuropeptides. The lipids release which occurs in response to stress 
is an additional factor for activation of macrophages and release of 
cytokines21. Therefore, the activation of the inflammatory process 
by the central nervous system helps to understand how a psycho-
logical process may cause through mediation of pro-inflammatory 
cytokines and oxygen and nitrogen intermediate reactives muscle, 
tendon and bursa injuries, in the absence of physical trauma22.
The present study had the aim to verify the incidence of mus-
culoskeletal injury without trauma in handball athletes relating its 
incidence to the production of cytokines and neurotransmitters. 
METHODOLOGY
Sample
The experimental protocol was approved by the Ethics 
Committee of the Institute of Biomedical Sciences of the University 
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of São Paulo. All subjects were informed about the aims and risks of 
the study, and their informed consent was obtained in a free and clear 
way, according to resolution 196/96 from the National Health Board. 
59 handball athletes, mean age of 31.9 ± 4.2 years, engaged 
in regular competitions and not presenting symptoms of acute 
infection or trauma were studied in the present study. The blood 
samples (20ml) were collected from an antecubital vein with the 
individuals at sitting position, before the training session (09:00h 
a.m.), after a minimum period of eight hours at fasting and 20 hours 
from the last training session, for analysis of cytokines production 
by mononuclear cells of the peripheral blood, and determination 
of the hormone and neurotransmitter concentration.
Clinical Assessment
Evaluation of injury without trauma occurred with analysis of the 
athletes’ medical records, being considered as injury without trauma 
patients those who visited the infirmary at least twice a month for 
six consecutive months, with complaint of injury in the soft tissues 
(muscles, tendons and bursas), without apparent trauma. Based 
on that evaluation, the athletes were divided in two groups: injury 
without trauma – repetitive stress injury (RSI) and athletes without 
repetitive injury (WI). As supporting instrument for evaluation of 
muscular pain, the athletes were submitted to clinical assessment 
following criteria by the American College of Rheumatology6, vali-
dated for the Brazilian population23, using the discomfort criterion 
through application of force of 4kg/cm2 on the spot proposed as 
fibromyalgia triggering-spots, a condition associated with chronic 
pain. Such instrument was used due to report by Small, relating 
chronic pain of the athlete with fibromyalgia5. The clinical evaluation 
was performed by an experienced rheumatologist. 
Hormone and neurotransmitter plasma concentration 
Each 10ml blood sample was transferred to a glass tube con-
taining 5ml of heparin (500IU/ml). The tubes were kept in ice until 
centrifugation at 960xg per 8min. The plasma concentration of 
cortisol, prolactin and growth hormone (GH) was measured by 
radioimmunoassay (commercial kit AIA-PACK, Medics Tosoh, Inc.). 
Adrenalin, dopamine, noradrenalin and L-dopa plasma levels were 
determined by high-performance liquid chromatography (HPLC), 
with electrochemical detection24. The chromatographic system (Shi-
madzu) was composed of a LC-10AD pump vp isocratic HPLC, a 
C18, RP 18 Brownlee 4.6 x 250mm of spherical 5ml, a steel column 
(Millipore Co), and an electrochemical detector L-ECD-6A opera-
ted in DC mode, controlled by the Shimadzu CLASS-VP software 
through a system interface module. The samples were eluded with 
a mixture: 20mM dibasic sodium; 20mM phosphate, in citric acid 
of pH 2.64 and 10% of methanol, Na2EDTA 0.12mM and 566mg/L 
of heptane sulphonic acid.
Determination of cytokines production
The total blood cells were plated (1.0 x 106 cells/ml) in plastic 
Petri dishes RPMI 1624 (medium enriched with glutamine 02mM, 
streptomycin 2.5mg/ml and penicillin 2.5UI/ml). After 48h, the 
concentrations of the IL-1, IL-2, IL-4, IL-6 cytokines, the interferon 
alpha (IFN-α) and the tumor necrosis factor alpha (TNF-α) were 
measured in the supernatant using ELISA kits (Quantikine®, R&D 
Systems, Inc). The prostaglandin E2 (PGE2) was measured using an 
Amersham Pharmacia Biotech kit (BiotrakTM). Total blood culture 
without stimulus was the choice to preserve the athletes’ conditions 
at the collection time.
STATISTICAL ANALYSIS
Data were considered parametric after a K-S test (α = 5%), and 
compared using Student’s t test and Welch correlation, whenever 
necessary. Minimal significance level of p < 0.05 was chosen for all 
statistical comparisons. Data are presented as mean ± SEM.
RESULTS
The evaluation of the medical records of the athletes indicated 
that 29% out of the 59 athletes presented repetitive strain injury 
without trauma and chronic muscular pain (group RSI). Additionally, 
it was observed that the group of athletes with highest incidence of 
musculoskeletal injuries without trauma presented higher number 
of painful spots to the clinical assessment (figure 1), with median 
of painful spots of 09, while athletes who did not present muscular 
repetitive strain injury presented median of five positive points. 
Concerning the plasma cortisol, prolactin, GH, adrenalin, 
noradrenalin, dopamine, L-dopa and creatinine concentrations, 
there was no significant difference between groups (table 1).
Increase in production of IL-1, IL-2, TNF-α, IFN-α and PGE2 was 
observed on the supernatant of cultures obtained from athletes of 
the group fibromyalgia, compared with the control group. The IL-4 
and IL-6 concentration in the supernatant of the cultures were not 
different between groups (table 2).
Figure 1. Median of the painful spots (0-18) comparing athletes with repetitive 
strain injuries (RSI) and athletes without repetitive strain injury (WI), detected by 
the doctor, through clinical evaluation and presence of musculoskeletal injuries, as 
evidenced by the medical records of the athletes (P = 0.0148).
Table 1. Concentration of plasma hormones and neurotransmitters comparing values 
obtained in fibromyalgia patients or non-patients.
SRI (n = 17) Control (n = 42) P value
noradrenalin (pg/ml) 88.64 ± 34.77 76.24 ± 51.18 0.405
adrenalin (pg/ml) 16.40 ± 13.64 26.84 ± 58.31 0.512
l-dopa (pg/ml) 250.83 ± 65.69 274.64 ± 107.89 0.442
dopamine (pg/ml) 263.03 ± 244.29 198.39 ± 120.99 0.198
gh (ng/ml) 2.04 ± 3.31 1.13 ± 2.10 0.242
prolactin (ng/ml) 8.75 ± 3.56 9.93 ± 5.40 0.469
cortisol (µg/dl) 15.31 ± 5.12 16.20 ± 4.27 0.528
creatinine (mg/dl) 182.17 ± 78.97 151.55 ± 55.46 0.117
The values are expressed in mean ± SEM.
Student’s t test and Welch correlation, p ≤ 0.05.
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cytokines and prostaglandine E2 suggests activation of the immu-
ne-inflammatory system, which, regardless of mechanical factor, 
suggests the activity of another mechanism.
The two groups of athletes presented positive triggering points 
to the exam; however, the group in which muscular repetitive strain 
injuries occurred presented median of positive points almost two 
times higher than the one presented by the group which did not 
present injuries. The positive and statistically significant correlation 
demonstrated between the number of positive triggering points 
and the increase of onset of nontraumatic injuries, suggests that 
these two findings may have an association. 
The report by Small5, relating chronic pain and fibromyalgia as 
the main complaint in sports medicine infirmaries, although can-
not allow the diagnosis of fibromyalgia in these athletes, makes us 
suppose that there may be a common pathogenic mechanism or 
that the final manifestation which produces the complaint is similar, 
so that the use of triggering points could be a simple manner to 
early detect the risk for muscular injury without trauma in athletes. 
CONCLUSION
An exacerbated immune-inflammatory response seems to be 
the physiopathogenic basis of muscular injury without trauma. 
Probably, many factors collaborate to this finding and it seems more 
to be an individual response to stress, be it physical or mental. This 
finding is important so that the team coaches and doctors are able 
to help the athletes who present repetitive injuries trying to refer 
the specialized service. Since the cytokine dosing currently is only 
available in research laboratories, the evaluation of triggering points 
by a trained doctor may be a diagnosis instrument which, joined 
to the athlete’s history, is able to diagnose muscular injury without 
trauma and help taking the necessary measures. 
Further studies with other modalities and with a higher number 
of athletes are necessary to corroborate our findings.
All authors have declared there is not any potential conflict of 
interests concerning this article.
Table 2. Cytokines production (IL-1, IL-2, IL-4 and IL-6, TNF-α and INF-α) and prosta-
glandin E2 (PGE2) by mononuclear cells of the peripheral blood stored by 48 hours, 
comparing values obtained in fibromyalgia syndrome patients and non-patients.
SRI (n = 17) Control (n = 42)  P value
IL-1 (ng/mL) 121.24 ± 44.37 44.36 ± 77.24 0.001
IL-2 (ng/mL) 122.42 ± 60.18 15.35 ± 6.37 0.0001
IL-4 (ng/mL) 80.19 ± 16.82 74.60 ± 14.49 0.28
IL-6 (ng/mL) 9.00 ± 11.18 11.55 ± 10.10 0.443
TNF-α (ng/mL) 297.61 ± 83.17 167.44 ± 120.04 0.0001
INF-α (U) 324.24 ± 136.04 86.19 ± 62.06 0.0001
Prostaglandin E2 (ng/mL) 570.38 ± 161.83 270.18 ± 97.00 0.0001
Results expressed in mean ± SEM.
Student’s t test and Welch correlation, p ≤ 0. 05.
DISCUSSION
It could be observed that an expressive number of athletes 
presented muscular repetitive strain injury (RSI) without trauma. 
It was associated with well-defined laboratory alteration, with 
increase of pro-inflammatory cytokines an activation of the immune-
inflammatory response. Such finding offers us the opportunity to 
build a rich information scenario which can have great value, both 
in the diagnosis and prevention of nontraumatic injury of athletes. 
The athletes included in this study were in their normal sports 
practice and did not present any apparent pathology. However, 
those who presented RSI presented laboratory alterations com-
patible with an inflammatory episode, evidenced by increase of 
pro-inflammatory cytokines and activation of immune system, pro-
ved by the increase of IL-2. Recently, Black20, when discussing the 
mechanisms associated with neurogenic inflammation, proposed 
that, in response to the psychological stress or to certain physical 
stressing agents, an inflammatory process may occur by the release 
of neuropeptides, with consequent activation of inflammatory cells. 
It is consistent in the literature the correlation between production 
of cytokines in response to psychological stressing agents18,19,25.
The stress hormones (cortisol, prolactine and GH), as well as 
the neurotransmitters, did not present differences between groups, 
suggesting that even if the athletes are submitted to similar physical 
stress, it would not be the factor associated with the pathogene-
sis of the scenario. However, the production of pro-inflammatory 
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